Skip to main content
. 2020 Dec 7;60(9):1457–1462. doi: 10.2169/internalmedicine.6028-20

Table.

Clinical Characteristics.

Patient 1 Patient 2 Patient 3 Patient 4
Diagnosis DPB DPB PCD PCD
Age, years/sex 70/man 71/man 52/man 40/man
Smoking status Ex-smoker (SI 50) Ex-smoker (SI 100) Ex-smoker (SI 50) Never
Chronic sinusitis + + + +
Childhood episodes of respiratory infection - - - -
Other information - - Infertility, visceral inversion Infertility
Laboratory findings
Cold agglutinin reaction (titer) +(256) - (32) - (32) - (32)
Autoantibodies - - - -
HTLV-1 and HIV antibodies - - - -
HLA A11/A24/B52/B60 A2/A24/B51/B61 A26/A33/B44/B61 A24/B54/B59
Sputum or broncho-lavage culture Haemophilus influenzae Non-significant Pseudomonas sp. Staphylococcus aureus Haemophilus influenzae Streptococcus pneumoniae
Pulmonary function
VC, % predicted 88 % 122 % 103 % 102 %
FEV1/FVC ratio (%) 61 % 64 % 82 % 68 %
DLco, % predicted 152 % 104 % 84 % 67 %
Ciliary structure under electron microscope Normal Normal Complete defects of inner dynein arm Partial defects of outer and inner dynein arm
Pathological findings by a cryobiopsy Respiratory bronchioles with various inflammation cells and foamy macrophages Bronchiolitis with high infiltration and peribronchiolar fibrosis Mild respiratory bronchiolitis Bronchiolitis obliterans involving terminal and respiratory bronchioles
Effects of macrolide therapy for six months Good Slightly worsened Slightly improved No change

DPB: diffuse panbronchiolitis, PCD: primary ciliary dyskinesia, SI: smoking index, HTLV-1: human T-cell leukemia virus type 1, HIV: human immunodeficiency virus, HLA: human leukocyte antigen, VC: vital capacity, FVC: forced vital capacity, FEV1: forced expiratory volume in 1 second, DLco, diffusing capacity of carbon monoxide